
Sign up to save your podcasts
Or


Attorneys Brady Bizarro and Andrew Silverio discuss today’s senate committee hearing on GLP-1 drug pricing and strategies that self-funded employers are using to manage the extreme costs of these drugs while we wait and hope for congressional action.
By The Phia Group4.9
1717 ratings
Attorneys Brady Bizarro and Andrew Silverio discuss today’s senate committee hearing on GLP-1 drug pricing and strategies that self-funded employers are using to manage the extreme costs of these drugs while we wait and hope for congressional action.

78,549 Listeners

32,056 Listeners

227,942 Listeners

63,456 Listeners

2,245 Listeners

585 Listeners

240 Listeners

111,908 Listeners

29 Listeners

1,432 Listeners

10,131 Listeners

15,888 Listeners

36 Listeners

19,066 Listeners

16,087 Listeners